Riente, L. “The Safety of Interleukin-1 Receptor Antagonist (anakinra) in the Treatment of Rheumatoid Arthritis”. Reumatismo, vol. 56, no. s1, Mar. 2004, pp. 74-79, doi:10.4081/reumatismo.2004.1s.74.